Larry D. Alphs

Dr. Alphs has a MD and PhD from the University of Chicago. He has had 10 years of experience in academia including psychiatric practice, and over 20 years of experience in industry. He has led work in all phases of clinical development from Phase I to IV with positions at Novartis, Knoll Pharmaceuticals, Pfizer, Janssen, Newron, and currently at Denovo Biopharma. He has led programs in numerous CNS disorders, including schizophrenia, bipolar disorder, suicidality, anxiety, depression, epilepsy, neuropathic pain, traumatic brain injury, and Rett Syndrome. He has authored over 200 publications, and developed several scales used in clinical trials, including for negative symptoms of schizophrenia, extrapyramidal symptoms, and suicide assessment.